nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—CYP3A4—type 2 diabetes mellitus	0.218	1	CbGaD
Zaleplon—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0556	0.14	CbGbCtD
Zaleplon—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0556	0.14	CbGbCtD
Zaleplon—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0417	0.105	CbGbCtD
Zaleplon—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0333	0.0838	CbGbCtD
Zaleplon—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0297	0.0747	CbGbCtD
Zaleplon—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0272	0.0683	CbGbCtD
Zaleplon—CYP3A5—Losartan—type 2 diabetes mellitus	0.0258	0.0649	CbGbCtD
Zaleplon—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0237	0.0597	CbGbCtD
Zaleplon—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0215	0.054	CbGbCtD
Zaleplon—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0163	0.0409	CbGbCtD
Zaleplon—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0156	0.0393	CbGbCtD
Zaleplon—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0156	0.0393	CbGbCtD
Zaleplon—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0148	0.0371	CbGbCtD
Zaleplon—CYP3A4—Glyburide—type 2 diabetes mellitus	0.011	0.0277	CbGbCtD
Zaleplon—CYP3A4—Losartan—type 2 diabetes mellitus	0.0101	0.0253	CbGbCtD
Zaleplon—TSPO—hindlimb—type 2 diabetes mellitus	0.0035	0.119	CbGeAlD
Zaleplon—TSPO—artery—type 2 diabetes mellitus	0.00214	0.0728	CbGeAlD
Zaleplon—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.00124	0.0421	CbGeAlD
Zaleplon—AOX1—islet of Langerhans—type 2 diabetes mellitus	0.00121	0.041	CbGeAlD
Zaleplon—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.00106	0.0361	CbGeAlD
Zaleplon—TSPO—islet of Langerhans—type 2 diabetes mellitus	0.00103	0.035	CbGeAlD
Zaleplon—AOX1—nephron tubule—type 2 diabetes mellitus	0.000971	0.033	CbGeAlD
Zaleplon—GABRB3—islet of Langerhans—type 2 diabetes mellitus	0.000935	0.0318	CbGeAlD
Zaleplon—TSPO—retina—type 2 diabetes mellitus	0.00088	0.0299	CbGeAlD
Zaleplon—AOX1—kidney—type 2 diabetes mellitus	0.000853	0.029	CbGeAlD
Zaleplon—AOX1—pancreas—type 2 diabetes mellitus	0.000847	0.0288	CbGeAlD
Zaleplon—AOX1—cortex of kidney—type 2 diabetes mellitus	0.000831	0.0282	CbGeAlD
Zaleplon—TSPO—nephron tubule—type 2 diabetes mellitus	0.000829	0.0282	CbGeAlD
Zaleplon—CYP3A7—liver—type 2 diabetes mellitus	0.00081	0.0275	CbGeAlD
Zaleplon—AOX1—adipose tissue—type 2 diabetes mellitus	0.000769	0.0261	CbGeAlD
Zaleplon—GABRA2—cortex of kidney—type 2 diabetes mellitus	0.000767	0.026	CbGeAlD
Zaleplon—TSPO—cardiovascular system—type 2 diabetes mellitus	0.000745	0.0253	CbGeAlD
Zaleplon—TSPO—kidney—type 2 diabetes mellitus	0.000729	0.0248	CbGeAlD
Zaleplon—TSPO—pancreas—type 2 diabetes mellitus	0.000724	0.0246	CbGeAlD
Zaleplon—TSPO—cortex of kidney—type 2 diabetes mellitus	0.00071	0.0241	CbGeAlD
Zaleplon—GABRA2—adipose tissue—type 2 diabetes mellitus	0.000709	0.0241	CbGeAlD
Zaleplon—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000689	0.0234	CbGeAlD
Zaleplon—GABRB3—pancreas—type 2 diabetes mellitus	0.000657	0.0223	CbGeAlD
Zaleplon—TSPO—adipose tissue—type 2 diabetes mellitus	0.000657	0.0223	CbGeAlD
Zaleplon—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000638	0.0217	CbGeAlD
Zaleplon—AOX1—liver—type 2 diabetes mellitus	0.000539	0.0183	CbGeAlD
Zaleplon—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000514	0.0174	CbGeAlD
Zaleplon—TSPO—liver—type 2 diabetes mellitus	0.000461	0.0156	CbGeAlD
Zaleplon—CYP3A5—kidney—type 2 diabetes mellitus	0.000451	0.0153	CbGeAlD
Zaleplon—CYP3A5—pancreas—type 2 diabetes mellitus	0.000448	0.0152	CbGeAlD
Zaleplon—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000439	0.0149	CbGeAlD
Zaleplon—GABRB3—liver—type 2 diabetes mellitus	0.000418	0.0142	CbGeAlD
Zaleplon—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000407	0.0138	CbGeAlD
Zaleplon—CYP3A4—kidney—type 2 diabetes mellitus	0.000339	0.0115	CbGeAlD
Zaleplon—CYP3A5—liver—type 2 diabetes mellitus	0.000285	0.00969	CbGeAlD
Zaleplon—CYP3A4—liver—type 2 diabetes mellitus	0.000214	0.00727	CbGeAlD
Zaleplon—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000132	0.000485	CcSEcCtD
Zaleplon—Chest pain—Metformin—type 2 diabetes mellitus	0.000131	0.000484	CcSEcCtD
Zaleplon—Myalgia—Metformin—type 2 diabetes mellitus	0.000131	0.000484	CcSEcCtD
Zaleplon—Malaise—Irbesartan—type 2 diabetes mellitus	0.000131	0.000484	CcSEcCtD
Zaleplon—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000131	0.000482	CcSEcCtD
Zaleplon—Headache—Pioglitazone—type 2 diabetes mellitus	0.000131	0.000482	CcSEcCtD
Zaleplon—Syncope—Irbesartan—type 2 diabetes mellitus	0.000131	0.000481	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.00013	0.000481	CcSEcCtD
Zaleplon—Visual impairment—Ramipril—type 2 diabetes mellitus	0.00013	0.00048	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00013	0.000479	CcSEcCtD
Zaleplon—Discomfort—Metformin—type 2 diabetes mellitus	0.00013	0.000479	CcSEcCtD
Zaleplon—Nausea—Glipizide—type 2 diabetes mellitus	0.000129	0.000477	CcSEcCtD
Zaleplon—Hypotension—Valsartan—type 2 diabetes mellitus	0.000129	0.000476	CcSEcCtD
Zaleplon—Pain—Gliclazide—type 2 diabetes mellitus	0.000129	0.000475	CcSEcCtD
Zaleplon—Constipation—Gliclazide—type 2 diabetes mellitus	0.000129	0.000475	CcSEcCtD
Zaleplon—Tremor—Losartan—type 2 diabetes mellitus	0.000128	0.000473	CcSEcCtD
Zaleplon—Rash—Glimepiride—type 2 diabetes mellitus	0.000128	0.000473	CcSEcCtD
Zaleplon—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000128	0.000472	CcSEcCtD
Zaleplon—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000128	0.000472	CcSEcCtD
Zaleplon—Rash—Sitagliptin—type 2 diabetes mellitus	0.000128	0.000471	CcSEcCtD
Zaleplon—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000128	0.000471	CcSEcCtD
Zaleplon—Headache—Glimepiride—type 2 diabetes mellitus	0.000127	0.000469	CcSEcCtD
Zaleplon—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000127	0.000469	CcSEcCtD
Zaleplon—Headache—Sitagliptin—type 2 diabetes mellitus	0.000127	0.000468	CcSEcCtD
Zaleplon—Anaemia—Losartan—type 2 diabetes mellitus	0.000127	0.000467	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000126	0.000465	CcSEcCtD
Zaleplon—Agitation—Losartan—type 2 diabetes mellitus	0.000126	0.000464	CcSEcCtD
Zaleplon—Oedema—Metformin—type 2 diabetes mellitus	0.000126	0.000464	CcSEcCtD
Zaleplon—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000126	0.000464	CcSEcCtD
Zaleplon—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000126	0.000464	CcSEcCtD
Zaleplon—Angioedema—Losartan—type 2 diabetes mellitus	0.000125	0.000462	CcSEcCtD
Zaleplon—Insomnia—Valsartan—type 2 diabetes mellitus	0.000125	0.000461	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000124	0.000459	CcSEcCtD
Zaleplon—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000124	0.000458	CcSEcCtD
Zaleplon—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000124	0.000457	CcSEcCtD
Zaleplon—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000124	0.000457	CcSEcCtD
Zaleplon—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000124	0.000457	CcSEcCtD
Zaleplon—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000124	0.000457	CcSEcCtD
Zaleplon—Shock—Metformin—type 2 diabetes mellitus	0.000124	0.000457	CcSEcCtD
Zaleplon—Insomnia—Orlistat—type 2 diabetes mellitus	0.000124	0.000456	CcSEcCtD
Zaleplon—Malaise—Losartan—type 2 diabetes mellitus	0.000124	0.000456	CcSEcCtD
Zaleplon—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000124	0.000455	CcSEcCtD
Zaleplon—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000123	0.000455	CcSEcCtD
Zaleplon—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000123	0.000455	CcSEcCtD
Zaleplon—Vertigo—Losartan—type 2 diabetes mellitus	0.000123	0.000454	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000123	0.000454	CcSEcCtD
Zaleplon—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000123	0.000454	CcSEcCtD
Zaleplon—Somnolence—Valsartan—type 2 diabetes mellitus	0.000123	0.000453	CcSEcCtD
Zaleplon—Syncope—Losartan—type 2 diabetes mellitus	0.000123	0.000453	CcSEcCtD
Zaleplon—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000123	0.000452	CcSEcCtD
Zaleplon—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000122	0.000452	CcSEcCtD
Zaleplon—Skin disorder—Metformin—type 2 diabetes mellitus	0.000122	0.000451	CcSEcCtD
Zaleplon—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000122	0.00045	CcSEcCtD
Zaleplon—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000122	0.000449	CcSEcCtD
Zaleplon—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000122	0.000449	CcSEcCtD
Zaleplon—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000121	0.000447	CcSEcCtD
Zaleplon—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000121	0.000447	CcSEcCtD
Zaleplon—Palpitations—Losartan—type 2 diabetes mellitus	0.000121	0.000446	CcSEcCtD
Zaleplon—Nausea—Glimepiride—type 2 diabetes mellitus	0.000121	0.000445	CcSEcCtD
Zaleplon—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.00012	0.000444	CcSEcCtD
Zaleplon—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00012	0.000444	CcSEcCtD
Zaleplon—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00012	0.000443	CcSEcCtD
Zaleplon—Asthenia—Glyburide—type 2 diabetes mellitus	0.00012	0.000443	CcSEcCtD
Zaleplon—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00012	0.000443	CcSEcCtD
Zaleplon—Anorexia—Metformin—type 2 diabetes mellitus	0.00012	0.000443	CcSEcCtD
Zaleplon—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00012	0.000441	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000119	0.00044	CcSEcCtD
Zaleplon—Alopecia—Ramipril—type 2 diabetes mellitus	0.000119	0.00044	CcSEcCtD
Zaleplon—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000119	0.000439	CcSEcCtD
Zaleplon—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000119	0.000439	CcSEcCtD
Zaleplon—Oedema—Irbesartan—type 2 diabetes mellitus	0.000119	0.000438	CcSEcCtD
Zaleplon—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000119	0.000438	CcSEcCtD
Zaleplon—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000119	0.000438	CcSEcCtD
Zaleplon—Pruritus—Glyburide—type 2 diabetes mellitus	0.000119	0.000437	CcSEcCtD
Zaleplon—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000118	0.000436	CcSEcCtD
Zaleplon—Constipation—Valsartan—type 2 diabetes mellitus	0.000118	0.000436	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000118	0.000435	CcSEcCtD
Zaleplon—Hypotension—Metformin—type 2 diabetes mellitus	0.000118	0.000434	CcSEcCtD
Zaleplon—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000117	0.000433	CcSEcCtD
Zaleplon—Shock—Irbesartan—type 2 diabetes mellitus	0.000117	0.000431	CcSEcCtD
Zaleplon—Pain—Orlistat—type 2 diabetes mellitus	0.000117	0.000431	CcSEcCtD
Zaleplon—Arthralgia—Losartan—type 2 diabetes mellitus	0.000117	0.00043	CcSEcCtD
Zaleplon—Myalgia—Losartan—type 2 diabetes mellitus	0.000117	0.00043	CcSEcCtD
Zaleplon—Chest pain—Losartan—type 2 diabetes mellitus	0.000117	0.00043	CcSEcCtD
Zaleplon—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000117	0.00043	CcSEcCtD
Zaleplon—Anxiety—Losartan—type 2 diabetes mellitus	0.000116	0.000429	CcSEcCtD
Zaleplon—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000116	0.000428	CcSEcCtD
Zaleplon—Rash—Bromocriptine—type 2 diabetes mellitus	0.000116	0.000426	CcSEcCtD
Zaleplon—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000115	0.000426	CcSEcCtD
Zaleplon—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000115	0.000426	CcSEcCtD
Zaleplon—Tension—Ramipril—type 2 diabetes mellitus	0.000115	0.000425	CcSEcCtD
Zaleplon—Discomfort—Losartan—type 2 diabetes mellitus	0.000115	0.000425	CcSEcCtD
Zaleplon—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000115	0.000424	CcSEcCtD
Zaleplon—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000115	0.000424	CcSEcCtD
Zaleplon—Headache—Bromocriptine—type 2 diabetes mellitus	0.000115	0.000424	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000115	0.000423	CcSEcCtD
Zaleplon—Nervousness—Ramipril—type 2 diabetes mellitus	0.000114	0.000421	CcSEcCtD
Zaleplon—Dry mouth—Losartan—type 2 diabetes mellitus	0.000114	0.000421	CcSEcCtD
Zaleplon—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000113	0.000418	CcSEcCtD
Zaleplon—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000113	0.000417	CcSEcCtD
Zaleplon—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000113	0.000417	CcSEcCtD
Zaleplon—Confusional state—Losartan—type 2 diabetes mellitus	0.000113	0.000416	CcSEcCtD
Zaleplon—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000113	0.000415	CcSEcCtD
Zaleplon—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000112	0.000414	CcSEcCtD
Zaleplon—Somnolence—Metformin—type 2 diabetes mellitus	0.000112	0.000413	CcSEcCtD
Zaleplon—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000112	0.000412	CcSEcCtD
Zaleplon—Oedema—Losartan—type 2 diabetes mellitus	0.000112	0.000412	CcSEcCtD
Zaleplon—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000112	0.000412	CcSEcCtD
Zaleplon—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000111	0.000409	CcSEcCtD
Zaleplon—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000111	0.000409	CcSEcCtD
Zaleplon—Tremor—Ramipril—type 2 diabetes mellitus	0.00011	0.000406	CcSEcCtD
Zaleplon—Shock—Losartan—type 2 diabetes mellitus	0.00011	0.000406	CcSEcCtD
Zaleplon—Urticaria—Valsartan—type 2 diabetes mellitus	0.00011	0.000405	CcSEcCtD
Zaleplon—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.00011	0.000404	CcSEcCtD
Zaleplon—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000109	0.000404	CcSEcCtD
Zaleplon—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000109	0.000403	CcSEcCtD
Zaleplon—Tachycardia—Losartan—type 2 diabetes mellitus	0.000109	0.000402	CcSEcCtD
Zaleplon—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000109	0.000402	CcSEcCtD
Zaleplon—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000109	0.000402	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000109	0.000401	CcSEcCtD
Zaleplon—Urticaria—Orlistat—type 2 diabetes mellitus	0.000109	0.0004	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000108	0.000399	CcSEcCtD
Zaleplon—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000108	0.000399	CcSEcCtD
Zaleplon—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000108	0.000398	CcSEcCtD
Zaleplon—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000108	0.000398	CcSEcCtD
Zaleplon—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000108	0.000398	CcSEcCtD
Zaleplon—Agitation—Ramipril—type 2 diabetes mellitus	0.000108	0.000398	CcSEcCtD
Zaleplon—Constipation—Metformin—type 2 diabetes mellitus	0.000108	0.000397	CcSEcCtD
Zaleplon—Angioedema—Ramipril—type 2 diabetes mellitus	0.000107	0.000396	CcSEcCtD
Zaleplon—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000107	0.000393	CcSEcCtD
Zaleplon—Anorexia—Losartan—type 2 diabetes mellitus	0.000107	0.000393	CcSEcCtD
Zaleplon—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000106	0.000393	CcSEcCtD
Zaleplon—Malaise—Ramipril—type 2 diabetes mellitus	0.000106	0.000391	CcSEcCtD
Zaleplon—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000106	0.000391	CcSEcCtD
Zaleplon—Rash—Glyburide—type 2 diabetes mellitus	0.000106	0.00039	CcSEcCtD
Zaleplon—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000106	0.00039	CcSEcCtD
Zaleplon—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000106	0.000389	CcSEcCtD
Zaleplon—Vertigo—Ramipril—type 2 diabetes mellitus	0.000106	0.000389	CcSEcCtD
Zaleplon—Syncope—Ramipril—type 2 diabetes mellitus	0.000105	0.000389	CcSEcCtD
Zaleplon—Headache—Glyburide—type 2 diabetes mellitus	0.000105	0.000387	CcSEcCtD
Zaleplon—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000105	0.000386	CcSEcCtD
Zaleplon—Hypotension—Losartan—type 2 diabetes mellitus	0.000104	0.000385	CcSEcCtD
Zaleplon—Palpitations—Ramipril—type 2 diabetes mellitus	0.000104	0.000383	CcSEcCtD
Zaleplon—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000104	0.000383	CcSEcCtD
Zaleplon—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000103	0.000381	CcSEcCtD
Zaleplon—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000103	0.000381	CcSEcCtD
Zaleplon—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000103	0.00038	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000103	0.000378	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000102	0.000376	CcSEcCtD
Zaleplon—Pain—Irbesartan—type 2 diabetes mellitus	0.000102	0.000375	CcSEcCtD
Zaleplon—Constipation—Irbesartan—type 2 diabetes mellitus	0.000102	0.000375	CcSEcCtD
Zaleplon—Insomnia—Losartan—type 2 diabetes mellitus	0.000101	0.000373	CcSEcCtD
Zaleplon—Paraesthesia—Losartan—type 2 diabetes mellitus	0.0001	0.00037	CcSEcCtD
Zaleplon—Urticaria—Metformin—type 2 diabetes mellitus	0.0001	0.000369	CcSEcCtD
Zaleplon—Chest pain—Ramipril—type 2 diabetes mellitus	0.0001	0.000369	CcSEcCtD
Zaleplon—Arthralgia—Ramipril—type 2 diabetes mellitus	0.0001	0.000369	CcSEcCtD
Zaleplon—Myalgia—Ramipril—type 2 diabetes mellitus	0.0001	0.000369	CcSEcCtD
Zaleplon—Dyspnoea—Losartan—type 2 diabetes mellitus	9.97e-05	0.000368	CcSEcCtD
Zaleplon—Anxiety—Ramipril—type 2 diabetes mellitus	9.97e-05	0.000368	CcSEcCtD
Zaleplon—Nausea—Glyburide—type 2 diabetes mellitus	9.96e-05	0.000367	CcSEcCtD
Zaleplon—Abdominal pain—Metformin—type 2 diabetes mellitus	9.95e-05	0.000367	CcSEcCtD
Zaleplon—Dizziness—Gliclazide—type 2 diabetes mellitus	9.95e-05	0.000367	CcSEcCtD
Zaleplon—Somnolence—Losartan—type 2 diabetes mellitus	9.94e-05	0.000367	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	9.93e-05	0.000366	CcSEcCtD
Zaleplon—Asthenia—Valsartan—type 2 diabetes mellitus	9.92e-05	0.000366	CcSEcCtD
Zaleplon—Discomfort—Ramipril—type 2 diabetes mellitus	9.88e-05	0.000364	CcSEcCtD
Zaleplon—Dyspepsia—Losartan—type 2 diabetes mellitus	9.84e-05	0.000363	CcSEcCtD
Zaleplon—Asthenia—Orlistat—type 2 diabetes mellitus	9.8e-05	0.000361	CcSEcCtD
Zaleplon—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9.79e-05	0.000361	CcSEcCtD
Zaleplon—Pruritus—Valsartan—type 2 diabetes mellitus	9.78e-05	0.000361	CcSEcCtD
Zaleplon—Dry mouth—Ramipril—type 2 diabetes mellitus	9.78e-05	0.000361	CcSEcCtD
Zaleplon—Decreased appetite—Losartan—type 2 diabetes mellitus	9.72e-05	0.000358	CcSEcCtD
Zaleplon—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.72e-05	0.000358	CcSEcCtD
Zaleplon—Confusional state—Ramipril—type 2 diabetes mellitus	9.67e-05	0.000357	CcSEcCtD
Zaleplon—Pruritus—Orlistat—type 2 diabetes mellitus	9.67e-05	0.000356	CcSEcCtD
Zaleplon—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	9.59e-05	0.000354	CcSEcCtD
Zaleplon—Oedema—Ramipril—type 2 diabetes mellitus	9.59e-05	0.000354	CcSEcCtD
Zaleplon—Constipation—Losartan—type 2 diabetes mellitus	9.56e-05	0.000353	CcSEcCtD
Zaleplon—Pain—Losartan—type 2 diabetes mellitus	9.56e-05	0.000353	CcSEcCtD
Zaleplon—Rash—Gliclazide—type 2 diabetes mellitus	9.49e-05	0.00035	CcSEcCtD
Zaleplon—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.48e-05	0.00035	CcSEcCtD
Zaleplon—Urticaria—Irbesartan—type 2 diabetes mellitus	9.44e-05	0.000348	CcSEcCtD
Zaleplon—Shock—Ramipril—type 2 diabetes mellitus	9.43e-05	0.000348	CcSEcCtD
Zaleplon—Headache—Gliclazide—type 2 diabetes mellitus	9.43e-05	0.000348	CcSEcCtD
Zaleplon—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.4e-05	0.000347	CcSEcCtD
Zaleplon—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.39e-05	0.000346	CcSEcCtD
Zaleplon—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.39e-05	0.000346	CcSEcCtD
Zaleplon—Tachycardia—Ramipril—type 2 diabetes mellitus	9.36e-05	0.000345	CcSEcCtD
Zaleplon—Skin disorder—Ramipril—type 2 diabetes mellitus	9.31e-05	0.000343	CcSEcCtD
Zaleplon—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.27e-05	0.000342	CcSEcCtD
Zaleplon—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.22e-05	0.00034	CcSEcCtD
Zaleplon—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.14e-05	0.000337	CcSEcCtD
Zaleplon—Dizziness—Valsartan—type 2 diabetes mellitus	9.14e-05	0.000337	CcSEcCtD
Zaleplon—Anorexia—Ramipril—type 2 diabetes mellitus	9.14e-05	0.000337	CcSEcCtD
Zaleplon—Dizziness—Orlistat—type 2 diabetes mellitus	9.03e-05	0.000333	CcSEcCtD
Zaleplon—Asthenia—Metformin—type 2 diabetes mellitus	9.03e-05	0.000333	CcSEcCtD
Zaleplon—Hypotension—Ramipril—type 2 diabetes mellitus	8.96e-05	0.00033	CcSEcCtD
Zaleplon—Nausea—Gliclazide—type 2 diabetes mellitus	8.94e-05	0.00033	CcSEcCtD
Zaleplon—Pruritus—Metformin—type 2 diabetes mellitus	8.91e-05	0.000328	CcSEcCtD
Zaleplon—Urticaria—Losartan—type 2 diabetes mellitus	8.88e-05	0.000328	CcSEcCtD
Zaleplon—Abdominal pain—Losartan—type 2 diabetes mellitus	8.84e-05	0.000326	CcSEcCtD
Zaleplon—Body temperature increased—Losartan—type 2 diabetes mellitus	8.84e-05	0.000326	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.74e-05	0.000322	CcSEcCtD
Zaleplon—Rash—Valsartan—type 2 diabetes mellitus	8.72e-05	0.000321	CcSEcCtD
Zaleplon—Dermatitis—Valsartan—type 2 diabetes mellitus	8.71e-05	0.000321	CcSEcCtD
Zaleplon—Insomnia—Ramipril—type 2 diabetes mellitus	8.67e-05	0.00032	CcSEcCtD
Zaleplon—Headache—Valsartan—type 2 diabetes mellitus	8.66e-05	0.000319	CcSEcCtD
Zaleplon—Rash—Orlistat—type 2 diabetes mellitus	8.61e-05	0.000318	CcSEcCtD
Zaleplon—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.61e-05	0.000317	CcSEcCtD
Zaleplon—Dermatitis—Orlistat—type 2 diabetes mellitus	8.61e-05	0.000317	CcSEcCtD
Zaleplon—Headache—Orlistat—type 2 diabetes mellitus	8.56e-05	0.000316	CcSEcCtD
Zaleplon—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.55e-05	0.000315	CcSEcCtD
Zaleplon—Asthenia—Irbesartan—type 2 diabetes mellitus	8.53e-05	0.000314	CcSEcCtD
Zaleplon—Somnolence—Ramipril—type 2 diabetes mellitus	8.52e-05	0.000314	CcSEcCtD
Zaleplon—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.44e-05	0.000311	CcSEcCtD
Zaleplon—Pruritus—Irbesartan—type 2 diabetes mellitus	8.41e-05	0.00031	CcSEcCtD
Zaleplon—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.34e-05	0.000307	CcSEcCtD
Zaleplon—Dizziness—Metformin—type 2 diabetes mellitus	8.33e-05	0.000307	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000305	CcSEcCtD
Zaleplon—Nausea—Valsartan—type 2 diabetes mellitus	8.21e-05	0.000303	CcSEcCtD
Zaleplon—Constipation—Ramipril—type 2 diabetes mellitus	8.2e-05	0.000302	CcSEcCtD
Zaleplon—Nausea—Orlistat—type 2 diabetes mellitus	8.12e-05	0.000299	CcSEcCtD
Zaleplon—Asthenia—Losartan—type 2 diabetes mellitus	8.02e-05	0.000296	CcSEcCtD
Zaleplon—Rash—Metformin—type 2 diabetes mellitus	7.94e-05	0.000293	CcSEcCtD
Zaleplon—Dermatitis—Metformin—type 2 diabetes mellitus	7.93e-05	0.000292	CcSEcCtD
Zaleplon—Pruritus—Losartan—type 2 diabetes mellitus	7.91e-05	0.000292	CcSEcCtD
Zaleplon—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.9e-05	0.000291	CcSEcCtD
Zaleplon—Headache—Metformin—type 2 diabetes mellitus	7.89e-05	0.000291	CcSEcCtD
Zaleplon—Dizziness—Irbesartan—type 2 diabetes mellitus	7.86e-05	0.00029	CcSEcCtD
Zaleplon—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.84e-05	0.000289	CcSEcCtD
Zaleplon—Urticaria—Ramipril—type 2 diabetes mellitus	7.62e-05	0.000281	CcSEcCtD
Zaleplon—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.58e-05	0.00028	CcSEcCtD
Zaleplon—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.58e-05	0.00028	CcSEcCtD
Zaleplon—Rash—Irbesartan—type 2 diabetes mellitus	7.49e-05	0.000276	CcSEcCtD
Zaleplon—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.49e-05	0.000276	CcSEcCtD
Zaleplon—Nausea—Metformin—type 2 diabetes mellitus	7.48e-05	0.000276	CcSEcCtD
Zaleplon—Headache—Irbesartan—type 2 diabetes mellitus	7.44e-05	0.000274	CcSEcCtD
Zaleplon—Dizziness—Losartan—type 2 diabetes mellitus	7.39e-05	0.000273	CcSEcCtD
Zaleplon—Nausea—Irbesartan—type 2 diabetes mellitus	7.06e-05	0.00026	CcSEcCtD
Zaleplon—Rash—Losartan—type 2 diabetes mellitus	7.05e-05	0.00026	CcSEcCtD
Zaleplon—Dermatitis—Losartan—type 2 diabetes mellitus	7.04e-05	0.00026	CcSEcCtD
Zaleplon—Headache—Losartan—type 2 diabetes mellitus	7.01e-05	0.000258	CcSEcCtD
Zaleplon—Asthenia—Ramipril—type 2 diabetes mellitus	6.88e-05	0.000254	CcSEcCtD
Zaleplon—Pruritus—Ramipril—type 2 diabetes mellitus	6.78e-05	0.00025	CcSEcCtD
Zaleplon—Nausea—Losartan—type 2 diabetes mellitus	6.64e-05	0.000245	CcSEcCtD
Zaleplon—Dizziness—Ramipril—type 2 diabetes mellitus	6.34e-05	0.000234	CcSEcCtD
Zaleplon—Rash—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000223	CcSEcCtD
Zaleplon—Dermatitis—Ramipril—type 2 diabetes mellitus	6.04e-05	0.000223	CcSEcCtD
Zaleplon—Headache—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000222	CcSEcCtD
Zaleplon—Nausea—Ramipril—type 2 diabetes mellitus	5.7e-05	0.00021	CcSEcCtD
Zaleplon—GABRA2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.45e-05	0.000293	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.44e-05	0.000291	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GCGR—type 2 diabetes mellitus	2.44e-05	0.000291	CbGpPWpGaD
Zaleplon—AOX1—Disease—CALM1—type 2 diabetes mellitus	2.43e-05	0.00029	CbGpPWpGaD
Zaleplon—AOX1—Disease—APOE—type 2 diabetes mellitus	2.42e-05	0.000289	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—LPL—type 2 diabetes mellitus	2.42e-05	0.000289	CbGpPWpGaD
Zaleplon—AOX1—Disease—APOA1—type 2 diabetes mellitus	2.39e-05	0.000286	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.39e-05	0.000286	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ADCY5—type 2 diabetes mellitus	2.37e-05	0.000283	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GPX1—type 2 diabetes mellitus	2.36e-05	0.000282	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	2.34e-05	0.000279	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HK1—type 2 diabetes mellitus	2.32e-05	0.000277	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—OXCT1—type 2 diabetes mellitus	2.3e-05	0.000275	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYTB—type 2 diabetes mellitus	2.3e-05	0.000275	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CD36—type 2 diabetes mellitus	2.3e-05	0.000275	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.27e-05	0.000271	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS2—type 2 diabetes mellitus	2.26e-05	0.00027	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GCKR—type 2 diabetes mellitus	2.24e-05	0.000268	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HSD3B2—type 2 diabetes mellitus	2.24e-05	0.000268	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—LPA—type 2 diabetes mellitus	2.24e-05	0.000268	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—KCNJ11—type 2 diabetes mellitus	2.24e-05	0.000268	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SRD5A1—type 2 diabetes mellitus	2.24e-05	0.000268	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.23e-05	0.000266	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—MTHFR—type 2 diabetes mellitus	2.18e-05	0.00026	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.18e-05	0.00026	CbGpPWpGaD
Zaleplon—AOX1—Disease—IRS1—type 2 diabetes mellitus	2.16e-05	0.000258	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALDOB—type 2 diabetes mellitus	2.15e-05	0.000257	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.15e-05	0.000256	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ACACA—type 2 diabetes mellitus	2.14e-05	0.000255	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HSD17B3—type 2 diabetes mellitus	2.14e-05	0.000255	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—STAR—type 2 diabetes mellitus	2.14e-05	0.000255	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PPARA—type 2 diabetes mellitus	2.14e-05	0.000255	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.09e-05	0.00025	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.07e-05	0.000248	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AGT—type 2 diabetes mellitus	2.07e-05	0.000247	CbGpPWpGaD
Zaleplon—AOX1—Disease—INS—type 2 diabetes mellitus	2.07e-05	0.000247	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CBS—type 2 diabetes mellitus	2.05e-05	0.000245	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCC8—type 2 diabetes mellitus	2.05e-05	0.000245	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CALM1—type 2 diabetes mellitus	2.04e-05	0.000243	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—APOE—type 2 diabetes mellitus	2.03e-05	0.000242	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—APOA1—type 2 diabetes mellitus	2.01e-05	0.00024	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKT2—type 2 diabetes mellitus	2e-05	0.000239	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GLP1R—type 2 diabetes mellitus	2e-05	0.000239	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC5A2—type 2 diabetes mellitus	1.97e-05	0.000236	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—COX2—type 2 diabetes mellitus	1.97e-05	0.000236	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.94e-05	0.000232	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NCOA6—type 2 diabetes mellitus	1.94e-05	0.000232	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.93e-05	0.000231	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HSD11B1—type 2 diabetes mellitus	1.91e-05	0.000228	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—UCP2—type 2 diabetes mellitus	1.91e-05	0.000228	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—UCP3—type 2 diabetes mellitus	1.91e-05	0.000228	CbGpPWpGaD
Zaleplon—AOX1—Disease—SERPINE1—type 2 diabetes mellitus	1.9e-05	0.000227	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.9e-05	0.000226	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLC2A2—type 2 diabetes mellitus	1.87e-05	0.000223	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CPT1A—type 2 diabetes mellitus	1.83e-05	0.000218	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—MTR—type 2 diabetes mellitus	1.83e-05	0.000218	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS3—type 2 diabetes mellitus	1.81e-05	0.000217	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3R1—type 2 diabetes mellitus	1.81e-05	0.000217	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NAMPT—type 2 diabetes mellitus	1.79e-05	0.000214	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PCK1—type 2 diabetes mellitus	1.79e-05	0.000214	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HBA1—type 2 diabetes mellitus	1.78e-05	0.000213	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GCK—type 2 diabetes mellitus	1.78e-05	0.000213	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—LIPC—type 2 diabetes mellitus	1.78e-05	0.000213	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP11A1—type 2 diabetes mellitus	1.77e-05	0.000211	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PPARG—type 2 diabetes mellitus	1.77e-05	0.000211	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLC9A1—type 2 diabetes mellitus	1.74e-05	0.000208	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—INS—type 2 diabetes mellitus	1.73e-05	0.000207	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CETP—type 2 diabetes mellitus	1.72e-05	0.000205	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HK1—type 2 diabetes mellitus	1.68e-05	0.0002	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTGS2—type 2 diabetes mellitus	1.66e-05	0.000198	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.66e-05	0.000198	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.66e-05	0.000198	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LPA—type 2 diabetes mellitus	1.62e-05	0.000194	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—KCNJ11—type 2 diabetes mellitus	1.62e-05	0.000194	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HSD3B2—type 2 diabetes mellitus	1.62e-05	0.000194	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GCKR—type 2 diabetes mellitus	1.62e-05	0.000194	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PSMD6—type 2 diabetes mellitus	1.6e-05	0.000191	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SNAP25—type 2 diabetes mellitus	1.6e-05	0.000191	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SREBF1—type 2 diabetes mellitus	1.6e-05	0.000191	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALB—type 2 diabetes mellitus	1.59e-05	0.00019	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CTGF—type 2 diabetes mellitus	1.57e-05	0.000187	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HMGCR—type 2 diabetes mellitus	1.55e-05	0.000186	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALDOB—type 2 diabetes mellitus	1.55e-05	0.000186	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ADRA2A—type 2 diabetes mellitus	1.52e-05	0.000182	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.52e-05	0.000182	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—NOS3—type 2 diabetes mellitus	1.52e-05	0.000182	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP2E1—type 2 diabetes mellitus	1.46e-05	0.000175	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.45e-05	0.000173	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.45e-05	0.000173	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP1A2—type 2 diabetes mellitus	1.44e-05	0.000173	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLC2A1—type 2 diabetes mellitus	1.44e-05	0.000173	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GLP1R—type 2 diabetes mellitus	1.44e-05	0.000173	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP3A4—type 2 diabetes mellitus	1.41e-05	0.000168	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTGS2—type 2 diabetes mellitus	1.39e-05	0.000166	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLC2A4—type 2 diabetes mellitus	1.38e-05	0.000165	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GCG—type 2 diabetes mellitus	1.38e-05	0.000165	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.37e-05	0.000164	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.37e-05	0.000164	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC2A2—type 2 diabetes mellitus	1.35e-05	0.000161	CbGpPWpGaD
Zaleplon—AOX1—Disease—SRC—type 2 diabetes mellitus	1.34e-05	0.00016	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—MTR—type 2 diabetes mellitus	1.32e-05	0.000158	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CPT1A—type 2 diabetes mellitus	1.32e-05	0.000158	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.31e-05	0.000157	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NAMPT—type 2 diabetes mellitus	1.3e-05	0.000155	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LIPC—type 2 diabetes mellitus	1.29e-05	0.000154	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HBA1—type 2 diabetes mellitus	1.29e-05	0.000154	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GCK—type 2 diabetes mellitus	1.29e-05	0.000154	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP11A1—type 2 diabetes mellitus	1.28e-05	0.000153	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC9A1—type 2 diabetes mellitus	1.26e-05	0.00015	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CETP—type 2 diabetes mellitus	1.24e-05	0.000148	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.21e-05	0.000145	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.21e-05	0.000145	CbGpPWpGaD
Zaleplon—AOX1—Disease—TGFB1—type 2 diabetes mellitus	1.2e-05	0.000143	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GNB3—type 2 diabetes mellitus	1.19e-05	0.000143	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.19e-05	0.000143	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HMOX1—type 2 diabetes mellitus	1.19e-05	0.000142	CbGpPWpGaD
Zaleplon—AOX1—Disease—EGFR—type 2 diabetes mellitus	1.18e-05	0.000141	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CAT—type 2 diabetes mellitus	1.17e-05	0.00014	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.17e-05	0.00014	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.17e-05	0.00014	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.17e-05	0.00014	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.17e-05	0.00014	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.17e-05	0.00014	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SNAP25—type 2 diabetes mellitus	1.15e-05	0.000138	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SREBF1—type 2 diabetes mellitus	1.15e-05	0.000138	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PSMD6—type 2 diabetes mellitus	1.15e-05	0.000138	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—APOB—type 2 diabetes mellitus	1.14e-05	0.000136	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CTGF—type 2 diabetes mellitus	1.13e-05	0.000135	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.13e-05	0.000135	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HMGCR—type 2 diabetes mellitus	1.12e-05	0.000134	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTM1—type 2 diabetes mellitus	1.11e-05	0.000132	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ADRA2A—type 2 diabetes mellitus	1.1e-05	0.000131	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—LPL—type 2 diabetes mellitus	1.09e-05	0.00013	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.07e-05	0.000128	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.07e-05	0.000128	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ADCY5—type 2 diabetes mellitus	1.06e-05	0.000127	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GPX1—type 2 diabetes mellitus	1.06e-05	0.000127	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	1.06e-05	0.000126	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	1.04e-05	0.000125	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	1.04e-05	0.000125	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.04e-05	0.000125	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CD36—type 2 diabetes mellitus	1.03e-05	0.000123	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPP2CA—type 2 diabetes mellitus	1.02e-05	0.000122	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	1.02e-05	0.000122	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	1e-05	0.00012	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	1e-05	0.00012	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	9.94e-06	0.000119	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	9.94e-06	0.000119	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	9.94e-06	0.000119	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—MTHFR—type 2 diabetes mellitus	9.78e-06	0.000117	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	9.6e-06	0.000115	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	9.53e-06	0.000114	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	9.53e-06	0.000114	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	9.3e-06	0.000111	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	9.17e-06	0.00011	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	9.17e-06	0.00011	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	9.14e-06	0.000109	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	9.11e-06	0.000109	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6—type 2 diabetes mellitus	9.04e-06	0.000108	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	9.01e-06	0.000108	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	9e-06	0.000108	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	8.86e-06	0.000106	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	8.86e-06	0.000106	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	8.86e-06	0.000106	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	8.63e-06	0.000103	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.63e-06	0.000103	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	8.59e-06	0.000103	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	8.47e-06	0.000101	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKT1—type 2 diabetes mellitus	8.34e-06	9.97e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	8.33e-06	9.95e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	8.23e-06	9.83e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	8e-06	9.56e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	7.93e-06	9.48e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	7.86e-06	9.39e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	7.8e-06	9.32e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	7.78e-06	9.3e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	7.69e-06	9.19e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	7.66e-06	9.16e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	7.53e-06	9e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	7.53e-06	9e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	7.53e-06	9e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	7.53e-06	9e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	7.46e-06	8.92e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	7.37e-06	8.81e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	7.22e-06	8.63e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	7.13e-06	8.53e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	7.07e-06	8.45e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AKT1—type 2 diabetes mellitus	6.99e-06	8.35e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	6.94e-06	8.29e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	6.82e-06	8.15e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	6.82e-06	8.15e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	6.72e-06	8.03e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.71e-06	8.02e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	6.61e-06	7.9e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	6.58e-06	7.87e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	6.51e-06	7.78e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.27e-06	7.49e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	6.24e-06	7.46e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.14e-06	7.34e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.14e-06	7.34e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	6.02e-06	7.2e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.98e-06	7.15e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.98e-06	7.15e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.98e-06	7.15e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.95e-06	7.11e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.84e-06	6.98e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.77e-06	6.9e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	5.74e-06	6.85e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	5.62e-06	6.72e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.37e-06	6.41e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.37e-06	6.41e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.37e-06	6.41e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.27e-06	6.3e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.22e-06	6.24e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	5.16e-06	6.16e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.11e-06	6.11e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	4.93e-06	5.89e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	4.93e-06	5.89e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.91e-06	5.87e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.85e-06	5.8e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.85e-06	5.8e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.65e-06	5.56e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.65e-06	5.56e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	4.51e-06	5.39e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.01e-06	4.79e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.01e-06	4.79e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.99e-06	4.77e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.94e-06	4.71e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.82e-06	4.57e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.72e-06	4.45e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.65e-06	4.36e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.58e-06	4.27e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.56e-06	4.26e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.47e-06	4.15e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.43e-06	4.09e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.29e-06	3.93e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.23e-06	3.85e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	3.14e-06	3.75e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.12e-06	3.73e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.07e-06	3.67e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.06e-06	3.66e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.03e-06	3.62e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.67e-06	3.19e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.62e-06	3.12e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.4e-06	2.86e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.29e-06	2.74e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.29e-06	2.74e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	2.27e-06	2.71e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.1e-06	2.51e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.05e-06	1.26e-05	CbGpPWpGaD
